News

A new handheld 3D printer can deposit sheets of skin to cover large burn wounds – and its “bio ink” can accelerate the healing process.

New research has found that rates of disease caused by the bacterium Streptococcus pneumoniae could be substantially reduced by changing our approach to vaccination.

Researchers have created a new type of chimeric antigen-receptor (CAR) T cell that can be switched on and off on demand.

Putrescine, the compound responsible for perhaps the foulest odor in nature—the smell of decomposing flesh—may also be a remedy for atherosclerosis and other chronic inflammatory diseases, according to a new study.

Two new studies outline strategies which will make it possible to eliminate cervical cancer within one hundred years.

Researchers are on the verge of considerably strengthening the therapeutic arsenal against viruses. By modifying sugar molecules, they have succeeded to destroy, by simple contact, many viruses, and in particular those responsible for respiratory infections and herpes infections.

Six patients undergoing stem cell gene therapy to treat a rare, inherited blood disease are now in remission.

A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody against malaria has begun enrolling healthy adult volunteers.

An interdisciplinary Munich research team led by scientists from TUM has for the first time succeeded in correcting the mutated dystrophin gene in living pigs. In order to cut the defective gene sequence from the DNA of the animals' muscle and heart cells, the researchers modified the Crispr-Cas9 gene scissors.

Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types--the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors-or vehicles--that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.